172 related articles for article (PubMed ID: 11027814)
1. Protection against hydatid disease induced with the EG95 vaccine is associated with conformational epitopes.
Woollard DJ; Gauci CG; Heath DD; Lightowlers MW
Vaccine; 2000 Oct; 19(4-5):498-507. PubMed ID: 11027814
[TBL] [Abstract][Full Text] [Related]
2. The immune response to a DNA vaccine can be modulated by co-delivery of cytokine genes using a DNA prime-protein boost strategy.
Scheerlinck JP; Casey G; McWaters P; Kelly J; Woollard D; Lightowlers MW; Tennent JM; Chaplin PJ
Vaccine; 2001 Jul; 19(28-29):4053-60. PubMed ID: 11427282
[TBL] [Abstract][Full Text] [Related]
3. Synthetic peptides induce antibody against a host-protective antigen of Echinococcus granulosus.
Woollard DJ; Gauci CG; Lightowlers MW
Vaccine; 1999 Dec; 18(9-10):785-94. PubMed ID: 10580190
[TBL] [Abstract][Full Text] [Related]
4. Epitope specificities and antibody responses to the EG95 hydatid vaccine.
Woollard DJ; Gauci CG; Heath DD; Lightowlers MW
Parasite Immunol; 1998 Nov; 20(11):535-40. PubMed ID: 9988310
[TBL] [Abstract][Full Text] [Related]
5. Assessment of protective immune responses against hydatid disease in sheep by immunization with synthetic peptide antigens.
Woollard DJ; Heath DD; Lightowlers MW
Parasitology; 2000 Aug; 121 ( Pt 2)():145-53. PubMed ID: 11085234
[TBL] [Abstract][Full Text] [Related]
6. Echinococcus granulosus: variability of the host-protective EG95 vaccine antigen in G6 and G7 genotypic variants.
Chow C; Gauci CG; Vural G; Jenkins DJ; Heath DD; Rosenzvit MC; Harandi MF; Lightowlers MW
Exp Parasitol; 2008 Aug; 119(4):499-505. PubMed ID: 18342311
[TBL] [Abstract][Full Text] [Related]
7. Short report: Echinococcus granulosus from Xinjiang, PR China: cDNAS encoding the EG95 vaccine antigen are expressed in different life cycle stages and are conserved in the oncosphere.
Zhang W; Li J; You H; Zhang Z; Turson G; Loukas A; McManus DP
Am J Trop Med Hyg; 2003 Jan; 68(1):40-3. PubMed ID: 12556145
[TBL] [Abstract][Full Text] [Related]
8. A novel in silico minigene vaccine based on CD4
Pourseif MM; Moghaddam G; Naghili B; Saeedi N; Parvizpour S; Nematollahi A; Omidi Y
Comput Biol Chem; 2018 Feb; 72():150-163. PubMed ID: 29195784
[TBL] [Abstract][Full Text] [Related]
9. Delivery of Echinococcus granulosus antigen EG95 to mice and sheep using recombinant vaccinia virus.
Dutton S; Fleming SB; Ueda N; Heath DD; Hibma MH; Mercer AA
Parasite Immunol; 2012 Jun; 34(6):312-7. PubMed ID: 22404504
[TBL] [Abstract][Full Text] [Related]
10. Antigenic differences between the EG95-related proteins from Echinococcus granulosus G1 and G6 genotypes: implications for vaccination.
Alvarez Rojas CA; Gauci CG; Lightowlers MW
Parasite Immunol; 2013 Feb; 35(2):99-102. PubMed ID: 23009356
[TBL] [Abstract][Full Text] [Related]
11. Serological monitoring of protection of sheep against Echinococcus granulosus induced by the EG95 vaccine.
Heath DD; Koolaard J
Parasite Immunol; 2012 Jan; 34(1):40-4. PubMed ID: 22043983
[TBL] [Abstract][Full Text] [Related]
12. Vaccination against hydatidosis using a defined recombinant antigen.
Lightowlers MW; Lawrence SB; Gauci CG; Young J; Ralston MJ; Maas D; Heath DD
Parasite Immunol; 1996 Sep; 18(9):457-62. PubMed ID: 9226681
[TBL] [Abstract][Full Text] [Related]
13. Vaccination trials in Australia and Argentina confirm the effectiveness of the EG95 hydatid vaccine in sheep.
Lightowlers MW; Jensen O; Fernandez E; Iriarte JA; Woollard DJ; Gauci CG; Jenkins DJ; Heath DD
Int J Parasitol; 1999 Apr; 29(4):531-4. PubMed ID: 10428628
[TBL] [Abstract][Full Text] [Related]
14. Immunity and vaccine control of Echinococcus granulosus infection in animal intermediate hosts.
Lightowlers MW; Heath DD
Parassitologia; 2004 Jun; 46(1-2):27-31. PubMed ID: 15305682
[TBL] [Abstract][Full Text] [Related]
15. The EG95 antigen of Echinococcus spp. contains positively selected amino acids, which may influence host specificity and vaccine efficacy.
Haag KL; Gottstein B; Ayala FJ
PLoS One; 2009; 4(4):e5362. PubMed ID: 19401778
[TBL] [Abstract][Full Text] [Related]
16. A gene family expressing a host-protective antigen of Echinococcus granulosus.
Chow C; Gauci CG; Cowman AF; Lightowlers MW
Mol Biochem Parasitol; 2001 Nov; 118(1):83-8. PubMed ID: 11704276
[TBL] [Abstract][Full Text] [Related]
17. Variability of the
Sreevatsava V; De S; Bandyopadhyay S; Chaudhury P; Bera AK; Muthiyan R; De AK; Perumal P; Sunder J; Chakraborty G; Bhattacharya D
J Genet; 2019 Jun; 98(2):. PubMed ID: 31204707
[TBL] [Abstract][Full Text] [Related]
18. Isolation of antibodies specific to a single conformation-dependant antigenic determinant on the EG95 hydatid vaccine.
Read AJ; Casey JL; Coley AM; Foley M; Gauci CG; Jackson DC; Lightowlers MW
Vaccine; 2009 Feb; 27(7):1024-31. PubMed ID: 19095030
[TBL] [Abstract][Full Text] [Related]
19. Development of orf virus as a bifunctional recombinant vaccine: surface display of Echinococcus granulosus antigen EG95 by fusion to membrane structural proteins.
Tan JL; Ueda N; Heath D; Mercer AA; Fleming SB
Vaccine; 2012 Jan; 30(2):398-406. PubMed ID: 22085551
[TBL] [Abstract][Full Text] [Related]
20. Echinococcus granulosus: oncosphere-specific transcription of genes encoding a host-protective antigen.
Chow C; Gauci CG; Cowman AF; Lightowlers MW
Exp Parasitol; 2004; 106(3-4):183-6. PubMed ID: 15172227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
